Martin Shkreli is tired of being pharma’s favorite scapegoat.

Shkreli, the former drug company CEO who rocketed to notoriety when he hiked the price of an old drug by 5,000 percent, routinely gets blamed by other pharma CEOs for tarnishing the reputation of the entire industry. On Monday, the trade group PhRMA launched a new multi-million dollar ad blitz specifically aimed at distancing itself from Shkreli.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.
  • This guys shrieking against his own industry reminds me of Sgt. Bergdahl whining about the Army after he was brought back for desertion.

    Ideally, President Trump will be the sumo wrestler the taxpayer needs to tackle and fling out of the ring Big Pharma.

    Wonder how many folks from Congress attended recent J.P. Morgan bash in SF? Between Wall Street and Big Pharma, they just spit in the eye of the taxpayer and laugh all the way up to the club floor of their hotels.

  • Not sure if it is genetic or learned, nature or nuture, but anyone in this industry that takes advantage of their niche monopoly to squeeze profits from anyone to prolong life has deluded themselves as much as their desparate customers delude themselves.
    No one lives forever. If you believe that’s it, one shot, make the most of it, grab as much respect for the buck then bankrupting fools like yourselves won’t get yo anything but disgust.
    If you believe otherwise you need a little education in empathy, sympathy, and compassion.

  • Wow. Well, maybe he can provide a constructive counter balance, but his own self-promoting grandiosity crushed him. On the other hand, there were tons of pharma execs at JP Morgan and Davos, spent literally thousands to mix and mingle in luxury, all the while running their companies with unbenefited contractors and draconian staff cutbacks. I welcome this admitted narcissist and social misfit as a contrarian blogger. Ultimately, the two fighting factions railing against each other just might lead to better pricing. One can only hope. And this dude knows about the skeletons big time.

  • how can i contact martin? I have a bunch of transgressions to add to this for big pharma. i think the best thing that could happen is for biotech to separate its message from big pharma. big pharma is too hated and too unethical and not innovative. JNJ is definitely one of the worst along with pfizer

  • It’s nice to hear a greedy shamed and demonized goat sell out the herd! The lies and denial of being a piece of garbage is delicious too! Let us not forget Shkreli’s two unforgettable unmentioned actions: buying a rap cd for a million bucks, and the statement that compared the price change decision to that of the same action if it were a bicycle business…. Million dollar Rap CDs are not research, and bicycles are not a survival necessity, medicine is. You’ll get our praise when you start really making up for who you were and what you did.

Comments are closed.

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy